Retatrutide vs Tirzepatide vs Semaglutide: Research Comparison
Retatrutide, tirzepatide and semaglutide are the three incretin-pathway research peptides most often compared in metabolic study design. They differ in how many receptors they engage, how they are typically reconstituted and stored, and what documentation should accompany each lot. This page summarises those differences side by side for laboratory reference. Research use only — not for human consumption.
Receptor targets at a glance
Semaglutide is a single-agonist research peptide directed at the GLP-1 receptor. Tirzepatide is a dual agonist engaging both GIP and GLP-1 receptors. Retatrutide is described as a triple agonist, adding glucagon-receptor activity to the GIP and GLP-1 targets. In published preclinical and clinical literature the breadth of receptor engagement is the primary variable investigators use to explain differences in observed metabolic outcomes. Amino Fuel Labs makes no therapeutic claim about any of these compounds.
Practical handling differences
All three are supplied lyophilized and are reconstituted with bacteriostatic water before use in a research setting. Vial mass differs — semaglutide and tirzepatide are commonly stocked in smaller masses than retatrutide's 10mg, 30mg and 50mg formats — so the same reconstitution volume produces different working concentrations. Investigators comparing the three should normalise concentration per mg rather than per vial, and should record the reconstitution volume in the study log.
Storage and stability
Lyophilized vials of all three remain stable under refrigeration and are best kept away from light and repeated temperature cycling. Once reconstituted, all three should be refrigerated and treated as short-window material; freeze-thaw cycling of a reconstituted solution is the most common avoidable source of degradation in comparison studies. Our full storage protocol is documented in the peptide storage guide.
Documentation to compare before you order
Any comparison between the three compounds is only as reliable as the material behind it. Confirm each lot carries a third-party Certificate of Analysis showing identity, reverse-phase HPLC purity, lot number and test date, and that the lot on the COA matches the vial label. Amino Fuel Labs releases every lot of retatrutide, tirzepatide and semaglutide research peptide against independent HPLC verification, with US same-day dispatch before the daily cutoff.
Related research peptides
Lab reports & documentation
Frequently asked questions
What is the main difference between the three?
Receptor breadth: semaglutide targets GLP-1, tirzepatide targets GIP and GLP-1, and retatrutide adds glucagon-receptor activity as a triple agonist.
Are they interchangeable in a study design?
No. Different receptor targets and vial masses mean concentrations and endpoints must be defined separately for each compound.
Do all three ship with a COA?
Yes. Every lot ships with third-party HPLC Certificate of Analysis documentation.
How should each be stored?
Lyophilized vials refrigerated and protected from light; reconstituted solutions refrigerated and not freeze-thaw cycled.
Are these approved for human use?
No. All material is supplied for laboratory research only and is not for human consumption.